Navigation Links
Labopharm appeals FDA's decision on once-daily tramadol
Date:10/15/2007

LAVAL, QC, Oct. 15 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that it has initiated the U.S. Food and Drug Administration (FDA)'s Formal Dispute Resolution process, appealing the Agency's decision regarding the Company's once-daily formulation of tramadol. Labopharm received a second Approvable Letter from the FDA for its once-daily formulation of tramadol in May of this year. The Company firmly believes it has met the statutory standards for approval of its once-daily tramadol formulation.

About the FDA's Formal Dispute Resolution Process

FDA regulations provide a mechanism for those seeking regulatory approval of a drug product through a New Drug Application (NDA) to obtain formal review of any Agency decision through a Formal Dispute Resolution process by raising the matter with the supervisor of the employee who made the decision. If the issue is not resolved at the primary supervisory level, the applicant may request that the matter be reviewed at the next higher supervisory level. This process may continue through the Agency's chain of command, through the Centers to the Commissioner of Food and Drugs. The Formal Dispute Resolution process exists to encourage open, prompt discussion of scientific (including medical) disputes and procedural (including administrative) disputes that arise during the drug development, new drug review, generic drug review, and post-marketing oversight processes.

About Labopharm Inc.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is being commercially launched in key markets globally. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become a fully integrated, international, specialty pharmaceutical company wit
'/>"/>

SOURCE Labopharm Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Kalam Appeals to Eradicate Hearing Disability
2. UNAIDS Chief Appeals for Projects to Battle AIDS/HIV
3. Man Appeals to President to Save His Ailing Son
4. Appeals Against The New Resolution By NICE Increases
5. Unicef Appeals To Prioritize Children In Fight Against AIDs
6. Swiss Group Appeals Invocation of Euthanasia Option For The Severely Depressed
7. Fidel Castro Appeals for Investment in Health Rather Than in Arms
8. FDAs Failure Urges It to Reassess Its Policies
9. FDAs Gesture for Firm Manufacturing Drug for Cushings Syndrome
10. People suffering from Alzheimer’s: can they take decisions about their treatment
11. Decision making made easier

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009).... 7 Tonight the House o...e for America Act, landmark health reform legislat...quality, affordable, stable and secure health care...ome of the insurance industry,s worst practices, w...ut the deficit by $104 billion over ten years. Gro...
(Date:11/8/2009)... Freeze-drying of biopharmaceuticals to be ava... facility. , Toronto, ON...dent and CEO of Therapure Biopharma Inc. today ann...mmercial scale pharmaceutical grade freeze dryer a...(lyophilization) available for contract manufactur...
(Date:11/8/2009).... 7 Today, the House of... Dahlkemper, Smith, Ellsworth and Lipinski amendme... (H.R. 3962). The amendment maintains the current ...and for benefits packages that include abortion. I...ve affordability credits and those who do not, can...
(Date:11/8/2009).... 7 USAction this eveni...r America Act, which will make health care more af...ccountable and increase access to health care for ..., "Teddy Roosevelt, FDR and Harry Truman would be...ey. "Today,s vote ranks among our country,s proude...
(Date:11/8/2009).... 8 The following was r...n Rescue Insurrecta Nex. ,, Mr. Terry and his ...ing to keep child-killing by abortion out of any h...: "This is a great first step to victory -- a touc... fighting ahead of us. Our rejoicing must be tempe...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2
...rifying case of blood transfusions probably turnin...4 more persons who had been given blood //transfus... of Jakob Creutz disease (vCJD). This was af...Lancet said blood transfusions appears to be an ef...
...ispensaries will do the rounds of rural areas as p...e needy and marginalized populations. // The... of Rs. 1.5 billion to states to set up mobile med...cheme for 2006-07. The document, tabled in ...
...-positive children were turned out of a school in ...en. // The MDLP School near Pampady district ...atened to withdraw their children from the school ...tes of Asha Kiran, an NGO formed under the aegis o...
...udy by specialists at the Johns Hopkins Children’s...ve inner-city children with chronic asthma //gets ...the disease. The findings, reported in Decemb... asthma attack strikes and to more complications a...
... City's Board of Health in a surprise move went ba... change the sex on their birth //certificates, wit... This proposal was keenly seconded by mental he...opposite' sexuality. Amid growing concerns ...
...ntless efforts of scientists to exploit prevailing...nd their value in impeding cognitive //decline in ...ypertensive agents, now the cynosure of scientists...ted with Alzheimer's. The research spearhead...
Other Medicine News:Health News:City Kids With Asthma Lose Out on Preventive Treatment 2
(Date:11/6/2009)...- Caraco Pharmaceutical Laboratories, Ltd. (NYSE A...hthalmic solution, 0.5% following a final approval...r Sun Pharma,s Abbreviated New Drug Application (A...n the first day following patent expiration. This ...t to Acular® Ophthalmic Solution, 0.5%, from ...
(Date:11/5/2009)...tCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a lead...regenerative healing, today reported financial res...9. ,, "During the third quarter of 2009, our fo...roducts MagniFuse(TM) Bone Graft, FacetLinx(TM) F...fting," said Sam Owusu-Akyaw, President and Chief ...
(Date:11/5/2009)...tCall/ -- Helix BioPharma Corp. (TSX, FSE: "HBP" /...rial of Topical Interferon Alpha-2b for the treatm...nt enrollment, with the required 120th patient ran... and placebo-controlled Phase II trial is underway...nts participating in the trial self-administer act...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimers Disease 13012 1Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimers Disease 13012 2Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimers Disease 13012 3Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimers Disease 13012 4SNICKERS 28R 29 Brand and David Arquette Make a Big Move to Help Feeding America Bar Hunger 51589 1SNICKERS 28R 29 Brand and David Arquette Make a Big Move to Help Feeding America Bar Hunger 51589 2SNICKERS 28R 29 Brand and David Arquette Make a Big Move to Help Feeding America Bar Hunger 51589 3SNICKERS 28R 29 Brand and David Arquette Make a Big Move to Help Feeding America Bar Hunger 51589 4Synthetic Genomics Inc and ExxonMobil Research and Engineering Company Sign Exclusive Multi Year Agreement to Develop Next Generation Biofuels Using 13011 1Synthetic Genomics Inc and ExxonMobil Research and Engineering Company Sign Exclusive Multi Year Agreement to Develop Next Generation Biofuels Using 13011 2Synthetic Genomics Inc and ExxonMobil Research and Engineering Company Sign Exclusive Multi Year Agreement to Develop Next Generation Biofuels Using 13011 3
...t,s actions today changing federal policy on embry... American Policy Roundtable and Dr. Charles McGowe... issued the following statement: , , "The Preside...ht of years of progress in the realm of autologous... is frozen in failure all over the world while aut...
...ty -- an Interventional Radiology Treatment -- Det...SAN DIEGO, March 9 Osteoplasty -- a highly effect...ful effects of metastatic bone disease by injectin...s immediate and substantial pain relief, often pre...h the miraculous so-called "Lazarus effect," accor...
Other Medicine Technology:Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 2Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 3Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 4Metastatic Bone Disease Patients Can Walk in Lazarus' Footsteps 5
... foot and ankle or deformity and leg lengthening c...ternal Fixation components are designed to reduce ...lexity of intra-operative and post-operative frame...ractors and hinges eliminate the need to stock lar...
Gold Standard Interference Screw
...g hip surgery. The Stulberg Hip Positioner is use... hip and revision surgery. It is designed to attac...isting table adapters. The upright pads are made ... and are sealed with a washable coating. The coati...
...fixation system for small bone orthopedic osteotom...ion and a superior screw and plating system in one...ag screws used for the fixation of the hand and fo...ed to overdrill the proximal segment while the low...
Medicine Products: